Position in PTCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$489,420
+$80,640 QoQ
Shares Held
6,000
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#226
of 383 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLAX POND CAPITAL, LLC holds $17,260,262 across 8 Biotechnology names. PTCT ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
156,726 | $7,218,799 | |
| 2 | NRIX |
Nurix Therapeutics, Inc.
|
79,700 | $1,933,522 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
36,000 | $1,932,120 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
56,838 | $1,897,820 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
41,302 | $1,539,325 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
7,933 | $1,485,692 | |
| 7 | BCYC |
Bicycle Therapeutics PLC
|
180,086 | $763,564 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
This page
|
6,000 | $489,420 |
All Filings in PTCT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,420 | 6,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $408,780 | 6,000 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $455,760 | 6,000 | Shares | Sole | 2026-03-09 | |
| No filing history on record for this holder in this stock. | ||||||